Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Strategies for Managing Compensated Liver Disease
February 2025
Non-selective β-blockers have demonstrated significant potential in preventing decompensation.
Read more
21 Sep 2015
Gout Medications May Be Effective In Treating Alcohol-Induced Liver Disease
COMMONLY used gout medications could offer protection from alcohol-induced liver disease and inflammation, according to the results of new research in mice.
21 Sep 2015
Liver Failure: Stem Cell Therapy Could Replace Liver Transplantation
STEM cell therapy could one day replace liver transplantation as the primary treatment for liver failure, according to a study which saw researchers…
22 Jun 2015
New Biomarkers Could Shine Beacon for Personalised Hepatitis C Therapy
BLOOD tests can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy. “While highly effective direct-acting…
22 Jun 2015
Starved T Cells Enable Undercover Liver Infection by Hepatitis B
HEPATITIS B has been shown to stimulate processes that deprive the body’s immune cells of key nutrients that they need to function. The findings explain…
30 Mar 2015
Endosialin an Integral Cog in the Liver Fibrosis Machine
DISCOVERY of a new molecule on the surface of hepatic stellate cells has broadened knowledge of the underlying mechanisms that cause liver fibrosis…
30 Mar 2015
Plant Compounds Represent a Budding Option for Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment
Plant compounds represent a budding option for Non-Alcoholic Fatty Liver Disease (NAFLD) treatment. Read the article and find out more
4 Feb 2015
AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C
MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…
12 Jan 2015
Artificial Liver Leads the Way as New Life-Saver
BIOARTIFICIAL livers could possess the ability to sustain liver failure (LF) patients until their own internal organs can repair themselves or…
Loading posts...
« Previous
1
…
18
19
20
21
Next »